37 results on '"Pinto, Valeria Maria"'
Search Results
2. Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations
3. Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization
4. Reduction of extramedullary erythropoiesis and amelioration of anemia in a β‐thalassemia patient treated with thalidomide
5. PB2530: DIXON-BASED R2* MRI AS AN INTEGRATION/SUBSTITUTE OF STANDARD T2*/R2* IN THE EVALUATION OF IRON OVERLOAD IN THE UPPER ABDOMEN
6. Management of the Sickle Cell Trait: An Opinion by Expert Panel Members
7. Inflammatory and senescence‐associated mediators affect the persistence of humoral response to COVID ‐19 mRNA vaccination in transfusion‐dependent beta‐thalassemic patients
8. Coinheritance of PIEZO1 variants and multi‐locus red blood cell defects account for the symptomatic phenotype in beta‐thalassemia carriers
9. Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose
10. Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting
11. Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy
12. Lack of correlation between heart, liver and pancreas MRI‐R2*: Results from long‐term follow‐up in a cohort of adult β‐thalassemia major patients
13. Overall and complication‐free survival in a large cohort of patients with β‐thalassemia major followed over 50 years.
14. Thalassaemia is paradoxically associated with a reduced risk of in‐hospital complications and mortality in COVID‐19: Data from an international registry
15. Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy
16. Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-thalassemia
17. Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-Thalassemia: additional dose role
18. Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection
19. Hemoglobin A2 and Heterogeneous Diagnostic Relevance Observed in Eight New Variants of the Delta Globin Gene
20. Hemoglobinopathies and Cancer: Preliminary Results of an Italian Multicenter Experience
21. Reduction of extramedullary erythropoiesis and amelioration of anemia in a β‐thalassemia patient treated with thalidomide.
22. Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series
23. COVID 19 and Hemoglobinopathies: Update of the Italian Experience
24. Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection.
25. Development of Algorithm for Clinical Management of Sickle Cell Bone Disease: Evidence for a Role of Vertebral Fractures in Patient Follow-up
26. Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm
27. Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion-dependent thalassemia patients
28. Noninvasive monitoring of liver fibrosis in sickle cell disease: Longitudinal observation of a cohort of adult patients
29. Criticità del D. M. 509
30. Hemoglobin A 2 and Heterogeneous Diagnostic Relevance Observed in Eight New Variants of the Delta Globin Gene.
31. Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose
32. Coinheritance of PIEZO1 variants and multi‐locus red blood cell defects account for the symptomatic phenotype in beta‐thalassemia carriers
33. Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations
34. Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy
35. Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection
36. Thalassemia Is Paradoxically Associated with a Reduced Risk of In-Hospital Complications and Mortality in COVID-19: Data from an International Registry
37. Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.